Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Widespread Adoption of AI Can Push This ETF Higher

BY | ETF Database
02/07/2025 | 642 VIEWS
The AI investing theme continues to gain momentum, offering traders a multitude of opportunities to capitalize on advancements in technology. As more adoption takes place on a massive scale, it could push the Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X ETF (UBOT B-) higher.The AI theme itself can open the door for long-term buy-and-hold plays, but also short-term plays. The capital markets saw  how AI news can quickly change the market landscape with the Chinese AI company DeepSeek. The announcement of its AI technology platform certainly shook the capital markets and movements like this give traders plenty of buy and sell opportunities. With widespread AI adoption occurring, the investment opportunities are seemingly endless. “Over the next five to 10 years, BofA Global Research expects gen AI to catalyze an evolution in corporate efficiency and productivity that may transform the global economy, as well as our lives,” said Vanessa Cook, content strategist for Bank of America Institute. Adoption is already occurring en masse across all business sectors. “The fields of customer service, marketing, and customer development are going to see massive adoption,” said Sheldon Monteiro, chief product officer at Publicis Sapient. “In these uses case, we have enough reference implementations to point to and say, ‘There’s value to be had here.’”One Trade for AI and MoreAs mentioned, with a myriad of opportunities available, it’s difficult to pinpoint one potential trade for exposure. One way is to simply trader entire industry and more with UBOT. UBOT seeks daily investment results equal to 200% of the daily performance of the Indxx Global Robotics and Artificial Intelligence Thematic Index (IBOTZNT). The index is designed to provide exposure to exchange-listed companies in developed markets. It looks at companies expected to benefit from the adoption and utilization of robotics and/or artificial intelligence. Salient characteristics of UBOT: The IBOTZNT provides exposure to exchange-listed companies in developed markets expected to benefit from robotics and artificial intelligence. It includes companies involved in developing industrial robots and production systems and automated inventory management. Additionally, it includes companies developing unmanned vehicles, voice/image/text recognition, and medical robots or robotic instruments. To qualify for inclusion in the index, companies must have a minimum market capitalization of $100 million. They must also have a minimum average daily turnover for the last six months greater than or equal to $2 million in order to be eligible for inclusion in the index. For more news, information, and analysis, visit the Leveraged & Inverse Channel.

More Commentary

Top Performing Leveraged/Inverse ETFs: 03/30/2025
BY | ETF Database
04/02/2025 | 6 VIEWS
Top Active ETF TCAF Adds More Than Half a Billion in 1 Month
BY | ETF Database
04/02/2025 | 43 VIEWS
Sell on the Pop Prospects: April 2 Edition
BY | ETF Database
04/02/2025 | 5 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.